Skip to content

Cyto-Stat Trichrome CD8-Fitc/CD4-Rdi/CD3-PC5 Monoclonal Antibody Reagent with Cyto-Stat Trichrome Msiggi-Fitc/Msiggi-RD1

by Coulter Corp.

510(k) K964618

Active European Union and United States

CE IVDD 510(k)

Valid until

Not listed

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK964618 Date23 Dec 1996ClearedStatusActive
European UnionCE/IVDD EUDAMED Number— Date—StatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k)

510(k) Number
FDA Product Code
GKZ
Device Class
Class II
Regulation
21 CFR Part 864.5220
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a three-color fluorescent reagent for flow cytometry, designed for the simultaneous identification and enumeration of specific lymphocyte subsets. It comprises three murine monoclonal antibodies—CD8-FITC, CD4-RD1, and CD3-PC5—each conjugated with distinct fluorochromes to enable multi-parametric analysis of CD3+, CD4+, and CD8+ cells, as well as dual-positive populations (CD3+/CD4+ and CD3+/CD8+).

The reagent is supplied as a ready-to-use solution for direct immunofluorescent staining in hematological flow cytometry applications. It is intended for single-use and requires no additional preparation beyond dilution as specified in the accompanying instructions. Authorized under FDA 510(k) clearance (K964618) and classified as an In Vitro Diagnostic Device (IVDD), it adheres to regulatory standards for medical specialty use in hematology. Storage and handling follow standard laboratory protocols for fluorescent reagents.

Other devices from Coulter Corp.

See all devices from Coulter Corp. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What specific cell types can this reagent identify and count simultaneously in a flow cytometry analysis?

    This reagent is designed for the simultaneous identification and enumeration of CD3+, CD4+, and CD8+ lymphocyte subsets, as well as dual-positive populations (CD3+/CD4+ and CD3+/CD8+). The three conjugated monoclonal antibodies—CD8-FITC, CD4-RD1, and CD3-PC5—enable multi-parametric analysis to distinguish these cell types in hematological samples.

  • Is this reagent intended for reuse, or is it meant to be used only once per sample?

    The reagent is explicitly labeled for single-use only, requiring no additional preparation beyond the specified dilution in the instructions. This ensures optimal performance and sterility for each flow cytometry analysis.

  • How should this reagent be stored, and are there any special handling requirements?

    Storage follows standard laboratory protocols for fluorescent reagents. While the data does not specify exact conditions, typical guidelines for such reagents include refrigeration (2–8°C) and protection from light to preserve fluorochrome integrity. Always refer to the accompanying instructions for precise storage details.

  • What regulatory pathways does this device follow, and what medical specialty is it authorized for?

    The reagent is authorized under FDA 510(k) clearance (K964618) and classified as an In Vitro Diagnostic Device (IVDD). It adheres to regulatory standards for hematology, as indicated by its advisory committee classification (HE) and medical specialty designation.

  • Does this reagent require any dilution or preparation before use in flow cytometry?

    No additional preparation is required beyond dilution as specified in the accompanying instructions. The reagent is supplied as a ready-to-use solution, simplifying workflow for direct immunofluorescent staining in hematological flow cytometry applications.